ÂÜÀòÂÒÂ×

Stephen Wargacki joined Aquestive in 2015. Prior to that Stephen led formulation development for Lohmann Therapy Systems. Dr. Wargacki’s 14 years in the pharmaceutical industry has been focused on alternative drug delivery including transdermal, sublingual, and buccal delivery systems as well as several medical devices.

From 2005 to 2008 he worked in the defense industry designing and developing novel sensors, initially at the Air Force Research Laboratory and subsequently in the private sector. Dr. Wargacki received his B.S. in Chemistry from the University of the Cumberlands and a PhD. in Polymer Chemistry from the University of Tennessee.